Synthetic biology - application-oriented cell engineering

Current Opinion in Biotechnology

Volumn 40, Issue , 2016, Pages 139-148

  Xie, Mingqi ^a   Haellman, Viktor ^a   Fussenegger, Martin ^a,b  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; CYTOLOGY; MAMMALS;

APPLICATION-ORIENTED; DESIGN PRINCIPLES; ENGINEERING PRINCIPLES; LIVING CELL; MAMMALIAN CELLS; REAL-WORLD PROBLEM; SYNTHETIC BIOLOGY;

CELL ENGINEERING;

TRANSCRIPTION ACTIVATOR LIKE EFFECTOR NUCLEASE; UNTRANSLATED RNA; ZINC FINGER NUCLEASE;

CELL ACTIVITY; CELL ENGINEERING; CELL FUNCTION; CYTOARCHITECTURE; GENE EXPRESSION; GENE LIBRARY; GENE SWITCHING; GENETIC TRANSCRIPTION; GENOME; HUMAN; MOLECULAR DIAGNOSTICS; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW; SYNTHETIC BIOLOGY; ANIMAL; PROCEDURES;

ANIMALS; CELL ENGINEERING; HUMANS; SYNTHETIC BIOLOGY;

EID: 84973091538     PISSN: 09581669     EISSN: 18790429     Source Type: Journal    
DOI: 10.1016/j.copbio.2016.04.005     Document Type: Review

References (75)

1. Green A.A., Silver P.A., Collins J.J., Yin P. Toehold switches: de-novo-designed regulators of gene expression. Cell 2014, 159:925-939.
2. Pardee K., Green A.A., Ferrante T., Cameron D.E., DaleyKeyser A., Yin P., Collins J.J. Paper-based synthetic gene networks. Cell 2014, 159:940-954.
3. Sternberg S.H., Doudna J.A. Expanding the biologist's toolkit with CRISPR-Cas9. Mol Cell 2015, 58:568-574.
4. Doudna J.A. Genomic engineering and the future of medicine. JAMA 2015, 313:791-792.
5. Briner A.E., Donohoue P.D., Gomaa A.A., Selle K., Slorach E.M., Nye C.H., Haurwitz R.E., Beisel C.L., May A.P., Barrangou R. Guide RNA functional modules direct Cas9 activity and orthogonality. Mol Cell 2014, 56:333-339.
6. Bolukbasi M.F., Gupta A., Oikemus S., Derr A.G., Garber M., Brodsky M.H., Zhu L.J., Wolfe S.A. DNA-binding-domain fusions enhance the targeting range and precision of Cas9. Nat Methods 2015, 12:1150-1156.
7. Fu Y., Sander J.D., Reyon D., Cascio V.M., Joung J.K. Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nat Biotechnol 2014, 32:279-284.
8. Cho S.W., Kim S., Kim Y., Kweon J., Kim H.S., Bae S., Kim J.S. Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases. Genome Res 2014, 24:132-141.
9. Richardson C.D., Ray G.J., DeWitt M.A., Curie G.L., Corn J.E. Enhancing homology-directed genome editing by catalytically active and inactive CRISPR-Cas9 using asymmetric donor DNA. Nat Biotechnol 2016, 34:339-344.
10. Lin S., Staahl B.T., Alla R.K., Doudna J.A. Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery. eLife 2014, 3:e04766.
11. Gao Y., Zhao Y. Self-processing of ribozyme-flanked RNAs into guide RNAs in vitro and in vivo for CRISPR-mediated genome editing. J Integr Plant Biol 2014, 56:343-349.
12. Nissim L., Perli S.D., Fridkin A., Perez-Pinera P., Lu T.K. Multiplexed and programmable regulation of gene networks with an integrated RNA and CRISPR/Cas toolkit in human cells. Mol Cell 2014, 54:698-710.
13. Shechner D.M., Hacisuleyman E., Younger S.T., Rinn J.L. Multiplexable, locus-specific targeting of long RNAs with CRISPR-display. Nat Methods 2015, 12:664-670.
14. Zetsche B., Gootenberg J.S., Abudayyeh O.O., Slaymaker I.M., Makarova K.S., Essletzbichler P., Volz S.E., Joung J., van der Oost J., Regev A., et al. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell 2015, 163:759-771.
15. O'Connell M.R., Oakes B.L., Sternberg S.H., East-Seletsky A., Kaplan M., Doudna J.A. Programmable RNA recognition and cleavage by CRISPR/Cas9. Nature 2014, 516:263-266.
16. Dahlman J.E., Abudayyeh O.O., Joung J., Gootenberg J.S., Zhang F., Konermann S. Orthogonal gene knockout and activation with a catalytically active Cas9 nuclease. Nat Biotechnol 2015, 33:1159-1161.
17. Kiani S., Chavez A., Tuttle M., Hall R.N., Chari R., Ter-Ovanesyan D., Qian J., Pruitt B.W., Beal J., Vora S., et al. Cas9 gRNA engineering for genome editing, activation and repression. Nat Methods 2015, 12:1051-1054.
18. Li Y., Jiang Y., Chen H., Liao W., Li Z., Weiss R., Xie Z. Modular construction of mammalian gene circuits using TALE transcriptional repressors. Nat Chem Biol 2015, 11:207-213.
19. Thakore P.I., D'Ippolito A.M., Song L., Safi A., Shivakumar N.K., Kabadi A.M., Reddy T.E., Crawford G.E., Gersbach C.A. Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements. Nat Methods 2015, 12:1143-1149.
20. Konermann S., Brigham M.D., Trevino A.E., Hsu P.D., Heidenreich M., Cong L., Platt R.J., Scott D.A., Church G.M., Zhang F. Optical control of mammalian endogenous transcription and epigenetic states. Nature 2013, 500:472-476.
21. Konermann S., Brigham M.D., Trevino A.E., Joung J., Abudayyeh O.O., Barcena C., Hsu P.D., Habib N., Gootenberg J.S., Nishimasu H., et al. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature 2015, 517:583-588.
22. Chavez A., Scheiman J., Vora S., Pruitt B.W., Tuttle M.E.P.R.I., Lin S., Kiani S., Guzman C.D., Wiegand D.J., et al. Highly efficient Cas9-mediated transcriptional programming. Nat Methods 2015, 12:326-328.
23. Keung A.J., Joung J.K., Khalil A.S., Collins J.J. Chromatin regulation at the frontier of synthetic biology. Nat Rev Genet 2015, 16:159-171.
24. Chen B., Hu J., Almeida R., Liu H., Balakrishnan S., Covill-Cooke C., Lim W.A., Huang B. Expanding the CRISPR imaging toolset with Staphylococcus aureus Cas9 for simultaneous imaging of multiple genomic loci. Nucleic Acids Res 2016.
25. Knight S.C., Xie L., Deng W., Guglielmi B., Witkowsky L.B., Bosanac L., Zhang E.T., El Beheiry M., Masson J.B., Dahan M., et al. Dynamics of CRISPR-Cas9 genome interrogation in living cells. Science 2015, 350:823-826.
26. Tanenbaum M.E., Gilbert L.A., Qi L.S., Weissman J.S., Vale R.D. A protein-tagging system for signal amplification in gene expression and fluorescence imaging. Cell 2014, 159:635-646.
27. Maeder M.L., Angstman J.F., Richardson M.E., Linder S.J., Cascio V.M., Tsai S.Q., Ho Q.H., Sander J.D., Reyon D., Bernstein B.E., et al. Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins. Nat Biotechnol 2013, 31:1137-1142.
28. Agne M., Blank I., Emhardt A.J., Gabelein C.G., Gawlas F., Gillich N., Gonschorek P., Juretschke T.J., Kramer S.D., Louis N., et al. Modularized CRISPR/dCas9 effector toolkit for target-specific gene regulation. ACS Synth Biol 2014, 3:986-989.
29. Kleinstiver B.P., Prew M.S., Tsai S.Q., Nguyen N.T., Topkar V.V., Zheng Z., Joung J.K. Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition. Nat Biotechnol 2015, 33:1293-1298.
30. Zalatan J.G., Lee M.E., Almeida R., Gilbert L.A., Whitehead E.H., La Russa M., Tsai J.C., Weissman J.S., Dueber J.E., Qi L.S., et al. Engineering complex synthetic transcriptional programs with CRISPR RNA scaffolds. Cell 2015, 160:339-350.
31. Slomovic S., Collins J.J. DNA sense-and-respond protein modules for mammalian cells. Nat Methods 2015, 12:1085-1090.
32. Auslander S., Fussenegger M. From gene switches to mammalian designer cells: present and future prospects. Trends Biotechnol 2013, 31:155-168.
33. Rossger K., Charpin-El-Hamri G., Fussenegger M. A closed-loop synthetic gene circuit for the treatment of diet-induced obesity in mice. Nat Commun 2013, 4:2825.
34. Xie M., Ye H., Charpin-El-Hamri G., Fussenegger M. Antagonistic control of a dual-input mammalian gene switch by food additives. Nucleic Acids Res 2014, 42:e116.
35. Wang H., Ye H., Xie M., Daoud El-Baba M., Fussenegger M. Cosmetics-triggered percutaneous remote control of transgene expression in mice. Nucleic Acids Res 2015, 43:e91.
36. 2 transgene-control device. Mol Cell 2014, 55:397-408.
37. Schukur L., Geering B., Charpin-El Hamri G., Fussenegger M. Implantable synthetic cytokine converter cells with AND-gate logic treat experimental psoriasis. Sci Transl Med 2015, 7. 318ra201.
38. Rossger K., Charpin-El Hamri G., Fussenegger M. Reward-based hypertension control by a synthetic brain-dopamine interface. Proc Natl Acad Sci U S A 2013, 110:18150-18155.
39. He L., Zhang Y., Ma G., Tan P., Li Z., Zang S., Wu X., Jing J., Fang S., Zhou L., et al. Near-infrared photoactivatable control of Ca(2+) signaling and optogenetic immunomodulation. eLife 2015, 4.
40. Muller K., Naumann S., Weber W., Zurbriggen M.D. Optogenetics for gene expression in mammalian cells. Biol Chem 2015, 396:145-152.
41. Folcher M., Oesterle S., Zwicky K., Thekkottil T., Heymoz J., Hohmann M., Christen M., Daoud El-Baba M., Buchmann P., Fussenegger M. Mind-controlled transgene expression by a wireless-powered optogenetic designer cell implant. Nat Commun 2014, 5:5392.
42. Kim T., Folcher M., Doaud-El Baba M., Fussenegger M. A synthetic erectile optogenetic stimulator enabling blue-light-inducible penile erection. Angew Chem Int Ed Engl 2015, 54:5933-5938.
43. Lienert F., Torella J.P., Chen J.H., Norsworthy M., Richardson R.R., Silver P.A. Two- and three-input TALE-based AND logic computation in embryonic stem cells. Nucleic Acids Res 2013, 41:9967-9975.
44. Nihongaki Y., Yamamoto S., Kawano F., Suzuki H., Sato M. CRISPR-Cas9-based photoactivatable transcription system. Chem Biol 2015, 22:169-174.
45. Polstein L.R., Gersbach C.A. A light-inducible CRISPR-Cas9 system for control of endogenous gene activation. Nat Chem Biol 2015, 11:198-200.
46. Muller K., Zurbriggen M.D., Weber W. Control of gene expression using a red- and far-red light-responsive bi-stable toggle switch. Nat Protoc 2014, 9:622-632.
47. Cao J., Arha M., Sudrik C., Bugaj L.J., Schaffer D.V., Kane R.S. Light-inducible activation of target mRNA translation in mammalian cells. Chem Commun (Camb) 2013, 49:8338-8340.
48. Kyung T., Lee S., Kim J.E., Cho T., Park H., Jeong Y.M., Kim D., Shin A., Kim S., Baek J., et al. Optogenetic control of endogenous Ca(2+) channels in vivo. Nat Biotechnol 2015, 33:1092-1096.
49. Lee S., Park H., Kyung T., Kim N.Y., Kim S., Kim J., Heo W.D. Reversible protein inactivation by optogenetic trapping in cells. Nat Methods 2014, 11:633-636.
50. Bugaj L.J., Choksi A.T., Mesuda C.K., Kane R.S., Schaffer D.V. Optogenetic protein clustering and signaling activation in mammalian cells. Nat Methods 2013, 10:249-252.
51. Wroblewska L., Kitada T., Endo K., Siciliano V., Stillo B., Saito H., Weiss R. Mammalian synthetic circuits with RNA binding proteins for RNA-only delivery. Nat Biotechnol 2015, 33:839-841.
52. Auslander S., Stucheli P., Rehm C., Auslander D., Hartig J.S., Fussenegger M. A general design strategy for protein-responsive riboswitches in mammalian cells. Nat Methods 2014, 11:1154-1160.
53. Kennedy A.B., Vowles J.V., d'Espaux L., Smolke C.D. Protein-responsive ribozyme switches in eukaryotic cells. Nucleic Acids Res 2014, 42:12306-12321.
54. Bloom R.J., Winkler S.M., Smolke C.D. A quantitative framework for the forward design of synthetic miRNA circuits. Nat Methods 2014, 11:1147-1153.
55. Wang T., Xie Y., Tan A., Li S., Xie Z. Construction and characterization of a synthetic microRNA cluster for multiplex RNA interference in mammalian cells. ACS Synth Biol 2015.
56. Beyer H.M., Juillot S., Herbst K., Samodelov S.L., Muller K., Schamel W.W., Romer W., Schafer E., Nagy F., Strahle U., et al. Red light-regulated reversible nuclear localization of proteins in mammalian cells and zebrafish. ACS Synth Biol 2015, 4:951-958.
57. Niopek D., Benzinger D., Roensch J., Draebing T., Wehler P., Eils R., Di Ventura B. Engineering light-inducible nuclear localization signals for precise spatiotemporal control of protein dynamics in living cells. Nat Commun 2014, 5:4404.
58. Spiltoir J.I., Strickland D., Glotzer M., Tucker C.L. Optical control of peroxisomal trafficking. ACS Synth Biol 2015.
59. Renicke C., Schuster D., Usherenko S., Essen L.O., Taxis C. A LOV2 domain-based optogenetic tool to control protein degradation and cellular function. Chem Biol 2013, 20:619-626.
60. Hughes R.M., Freeman D.J., Lamb K.N., Pollet R.M., Smith W.J., Lawrence D.S. Optogenetic apoptosis: light-triggered cell death. Angew Chem Int Ed Engl 2015, 54:12064-12068.
61. Lienert F., Lohmueller J.J., Garg A., Silver P.A. Synthetic biology in mammalian cells: next generation research tools and therapeutics. Nat Rev Mol Cell Biol 2014, 15:95-107.
62. Zhang J., Jensen M.K., Keasling J.D. Development of biosensors and their application in metabolic engineering. Curr Opin Chem Biol 2015, 28:1-8.
63. Paddon C.J., Keasling J.D. Semi-synthetic artemisinin: a model for the use of synthetic biology in pharmaceutical development. Nat Rev Microbiol 2014, 12:355-367.
64. Menzel A., Gubeli R.J., Guder F., Weber W., Zacharias M. Detection of real-time dynamics of drug-target interactions by ultralong nanowalls. Lab Chip 2013, 13:4173-4179.
65. Singh M.S., Peer D. RNA nanomedicines: the next generation drugs?. Curr Opin Biotechnol 2016, 39:28-34.
66. Wong A.S., Choi G.C., Cheng A.A., Purcell O., Lu T.K. Massively parallel high-order combinatorial genetics in human cells. Nat Biotechnol 2015, 33:952-961.
67. Courbet A., Endy D., Renard E., Molina F., Bonnet J. Detection of pathological biomarkers in human clinical samples via amplifying genetic switches and logic gates. Sci Transl Med 2015, 7. 289ra283.
68. Auslander D., Eggerschwiler B., Kemmer C., Geering B., Auslander S., Fussenegger M. A designer cell-based histamine-specific human allergy profiler. Nat Commun 2014, 5:4408.
69. Schukur L., Geering B., Fussenegger M. Human whole-blood culture system for ex vivo characterization of designer-cell function. Biotechnol Bioeng 2016, 113:588-597.
70. Yang H.K., Yoon K.H. Current status of encapsulated islet transplantation. J Diabetes Complicat 2015, 29:737-743.
71. Jullesson D., David F., Pfleger B., Nielsen J. Impact of synthetic biology and metabolic engineering on industrial production of fine chemicals. Biotechnol Adv 2015, 33:1395-1402.
72. Vashist S.K., Luppa P.B., Yeo L.Y., Ozcan A., Luong J.H. Emerging technologies for next-generation point-of-care testing. Trends Biotechnol 2015, 33:692-705.
73. Heng B.C., Aubel D., Fussenegger M. Prosthetic gene networks as an alternative to standard pharmacotherapies for metabolic disorders. Curr Opin Biotechnol 2015, 35:37-45.
74. Guye P., Ebrahimkhani M.R., Kipniss N., Velazquez J.J., Schoenfeld E., Kiani S., Griffith L.G., Weiss R. Genetically engineering self-organization of human pluripotent stem cells into a liver bud-like tissue using Gata6. Nat Commun 2016, 7:10243.
75. Saxena P., Heng B.C., Bai P., Folcher M., Zulewski H., Fussenegger M. A programmable synthetic lineage-control network that differentiates human iPSCs into glucose-sensitive insulin-secreting beta-like cells. Nat Commun 2016, 7:11247. PMID: 27063289.